DEXCOM, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
DEXCOM, INC. (DXCM) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $718.50 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-02-27
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $171.20M, a 30.89% increase year-over-year.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $148.60M, a 42.61% increase year-over-year.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $137.30M, a 47.79% increase year-over-year.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $116.20M, a 59.62% increase year-over-year.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $718.50M, a 25.33% increase from fiscal 2016.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $573.30M, a 43.07% increase from fiscal 2015.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $400.70M, a 55.85% increase from fiscal 2014.
- DEXCOM, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $257.10M, a 63.65% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $718.50M 10-K · filed 2018-02-27 | |||||||
| 2016-12-31 | $171.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $319.80M derived: sum of 2 quarters · filed 2018-02-27 | $457.10M derived: sum of 3 quarters · filed 2018-02-27 | $573.30M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $148.60M 10-Q · filed 2016-11-01 | $285.90M derived: sum of 2 quarters · filed 2016-11-01 | $402.10M 10-Q · filed 2016-11-01 | $532.90M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $137.30M 10-Q · filed 2016-08-02 | $253.50M 10-Q · filed 2016-08-02 | $384.30M derived: sum of 3 quarters · filed 2018-02-27 | $488.50M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $116.20M 10-Q · filed 2016-04-27 | $247.00M derived: sum of 2 quarters · filed 2018-02-27 | $351.20M derived: sum of 3 quarters · filed 2018-02-27 | $444.10M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $130.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $235.00M derived: sum of 2 quarters · filed 2018-02-27 | $327.90M derived: sum of 3 quarters · filed 2018-02-27 | $400.70M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $104.20M 10-Q · filed 2016-11-01 | $197.10M derived: sum of 2 quarters · filed 2016-11-01 | $269.90M 10-Q · filed 2016-11-01 | $354.20M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $92.90M 10-Q · filed 2016-08-02 | $165.70M 10-Q · filed 2016-08-02 | $250.00M derived: sum of 3 quarters · filed 2017-02-28 | $317.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $72.80M 10-Q · filed 2016-04-27 | $157.10M derived: sum of 2 quarters · filed 2017-02-28 | $225.00M derived: sum of 3 quarters · filed 2017-02-28 | $283.20M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $84.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $152.20M derived: sum of 2 quarters · filed 2017-02-28 | $210.40M derived: sum of 3 quarters · filed 2017-02-28 | $257.10M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $67.90M 10-Q · filed 2015-11-04 | $126.10M derived: sum of 2 quarters · filed 2015-11-04 | $172.80M 10-Q · filed 2015-11-04 | $224.10M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $58.20M 10-Q · filed 2015-08-05 | $104.90M 10-Q · filed 2015-08-05 | $156.20M derived: sum of 3 quarters · filed 2016-02-23 | $198.70M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $46.70M 10-Q · filed 2015-04-29 | $98.00M derived: sum of 2 quarters · filed 2016-02-23 | $140.50M derived: sum of 3 quarters · filed 2016-02-23 | $176.00M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $51.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $93.80M derived: sum of 2 quarters · filed 2016-02-23 | $129.30M derived: sum of 3 quarters · filed 2016-02-23 | $157.10M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $42.50M 10-Q · filed 2014-11-06 | $78.00M derived: sum of 2 quarters · filed 2014-11-06 | $105.80M 10-Q · filed 2014-11-06 | $137.60M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $35.50M 10-Q · filed 2014-08-06 | $63.30M 10-Q · filed 2014-08-06 | $95.10M derived: sum of 3 quarters · filed 2015-02-25 | $116.20M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $27.80M 10-Q · filed 2014-05-01 | $59.60M derived: sum of 2 quarters · filed 2015-02-25 | $80.70M derived: sum of 3 quarters · filed 2015-02-25 | $102.20M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $52.90M derived: sum of 2 quarters · filed 2015-02-25 | $74.40M derived: sum of 3 quarters · filed 2015-02-25 | $93.00M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | $21.10M 10-Q · filed 2013-11-06 | $21.08M 10-Q · filed 2012-11-01 | $42.60M derived: sum of 2 quarters · filed 2013-11-06 | $61.20M 10-Q · filed 2013-11-06 | $61.22M 10-Q · filed 2012-11-01 | $82.13M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $21.50M 10-Q · filed 2013-08-07 | $21.52M 10-Q · filed 2012-08-06 | $40.10M 10-Q · filed 2013-08-07 | $40.14M 10-Q · filed 2012-08-06 | $61.03M derived: sum of 3 quarters · filed 2014-02-20 | $77.68M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | $18.60M 10-Q · filed 2013-05-01 | $18.62M 10-Q · filed 2012-05-02 | $39.53M derived: sum of 2 quarters · filed 2014-02-20 | $56.18M derived: sum of 3 quarters · filed 2014-02-20 | $71.36M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | $20.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $37.58M derived: sum of 2 quarters · filed 2014-02-20 | $52.76M derived: sum of 3 quarters · filed 2014-02-20 | $65.90M 10-K · filed 2014-02-20 | $65.91M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | $16.66M 10-Q · filed 2012-11-01 | $31.84M derived: sum of 2 quarters · filed 2012-11-01 | $44.97M 10-Q · filed 2012-11-01 | $58.59M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $15.18M 10-Q · filed 2012-08-06 | $28.32M 10-Q · filed 2012-08-06 | $41.94M derived: sum of 3 quarters · filed 2013-02-21 | $52.71M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $13.14M 10-Q · filed 2012-05-02 | $26.76M derived: sum of 2 quarters · filed 2013-02-21 | $37.53M derived: sum of 3 quarters · filed 2013-02-21 | $46.58M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $13.62M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $24.39M derived: sum of 2 quarters · filed 2013-02-21 | $33.44M derived: sum of 3 quarters · filed 2013-02-21 | $40.20M 10-K · filed 2013-02-21 | $40.17M 10-K · filed 2012-02-23 | |||
| 2010-09-30 | $10.78M 10-Q · filed 2011-11-02 | $19.82M derived: sum of 2 quarters · filed 2011-11-02 | $26.58M 10-Q · filed 2011-11-02 | |||||
| 2010-06-30 | $9.04M 10-Q · filed 2011-08-03 | $15.81M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-31 | $18.04M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |